Home » Stocks » FLGT

Fulgent Genetics, Inc. (FLGT)

Stock Price: $69.24 USD 3.01 (4.54%)
Updated Jan 22, 2021 4:00 PM EST - Market closed
Market Cap 1.61B
Revenue (ttm) 135.12M
Net Income (ttm) 47.71M
Shares Out 22.06M
EPS (ttm) 2.14
PE Ratio 32.36
Forward PE 13.64
Dividend n/a
Dividend Yield n/a
Trading Day January 22
Last Price $69.24
Previous Close $66.23
Change ($) 3.01
Change (%) 4.54%
Day's Open 66.42
Day's Range 65.99 - 69.47
Day's Volume 1,118,374
52-Week Range 6.75 - 76.74

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Benzinga - 18 hours ago

Typically speaking, contrarian involves going against the grain, either by buying stocks most other investors are selling, or vice versa.  Yet, this exact sentiment towards contrarian investin...

Other stocks mentioned: DDOG
Zacks Investment Research - 1 week ago

FULGENT GENETIC (FLGT) closed at $69.07 in the latest trading session, marking a -1.1% move from the prior day.

The Motley Fool - 1 week ago

Both of these businesses prospered even during a volatile year -- and the coming months could be even more impressive.

Other stocks mentioned: TWLO
The Motley Fool - 1 week ago

These winners are positioned for gains even after COVID.

Other stocks mentioned: GNMK, NTRA, NVS, PFE
The Motley Fool - 2 weeks ago

A Wall Street analyst downgraded the genetics testing provider.

Zacks Investment Research - 2 weeks ago

As of late, it has definitely been a great time to be an investor in Fulgent Genetics (FLGT).

GlobeNewsWire - 2 weeks ago

TEMPLE CITY, Calif., Jan. 06, 2021 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio...

Seeking Alpha - 2 weeks ago

Fulgent's core genetic testing business is recovering and should improve even further due to synergies with the COVID-19 business. Many people thought COVID-19 would dissipate in 2021 as the v...

The Motley Fool - 3 weeks ago

Both of these stocks are up more than 300% in 2020 and have room to run.

Other stocks mentioned: CELH
The Motley Fool - 3 weeks ago

Helping the world cope with a pandemic increased sales by several multiples for these companies.

Other stocks mentioned: ZM
The Motley Fool - 3 weeks ago

Investors in fast-moving biotechs made out like bandits.

Other stocks mentioned: CODX, INO, MRNA, ARCT
GlobeNewsWire - 3 weeks ago

Following a competitive process, Fulgent was selected to extend its support of the NYC DOE public school testing managed by the NYC Test and Trace Corps with on-site staffing and RT-PCR tests ...

The Motley Fool - 3 weeks ago

Could this genetic testing provider turn its coronavirus bump into long-term share price growth?

Zacks Investment Research - 4 weeks ago

We discuss four MedTech stocks, CDNA, FLGT, OMI and QDEL that more than doubled in 2020, and are poised to maintain market beating momentum in 2021 on strong fundamentals.

Other stocks mentioned: CDNA, OMI, QDEL
The Motley Fool - 1 month ago

Companies with fast growth and predictable trends are better bets in a frothy market.

Other stocks mentioned: ABNB, CHWY
Zacks Investment Research - 1 month ago

Check out these five high earnings yield stocks that can make you rich, irrespective of the Santa rally or a year-end pullback.

Other stocks mentioned: ALLY, GM, QFIN, WGO
The Motley Fool - 1 month ago

Should you invest in shares of this high-flying coronavirus stock before it's too late?

The Motley Fool - 1 month ago

The encore to a great 2019: Even more gains this year.

Zacks Investment Research - 1 month ago

Here are a few MedTech growth stocks poised for a rebound that investors can scoop up to reap profits going into 2021.

Other stocks mentioned: ADUS, HOLX
Zacks Investment Research - 1 month ago

Top Ranked Momentum Stocks to Buy for December 10th

Other stocks mentioned: ITRN, NOG, PLT
The Motley Fool - 1 month ago

Although vaccine makers are dominating headlines, these diagnostic companies will remain relevant in the fight against COVID-19.

Other stocks mentioned: QDEL
The Motley Fool - 1 month ago

The COVID-19 pandemic continues to provide a tailwind for the genetic testing specialist.

The Motley Fool - 1 month ago

There are plenty of healthcare stocks that have seen share growth this year. Here are three lesser-known stocks that have the potential to continue that growth this month and beyond.

Other stocks mentioned: WST, FPRX
The Motley Fool - 1 month ago

Investors have been selling these stocks, but patient investors should take advantage of the opportunity.

Other stocks mentioned: CVS, EBS
The Motley Fool - 1 month ago

Wall Street seems worried that the arrival of coronavirus vaccines will take the wind out of the sails of this genetic and medical testing company. That view misses the big picture.

InvestorPlace - 1 month ago

Here are seven of the best cheap stocks for December that I'd consider buying The post 7 of the Best Cheap Stocks for December appeared first on InvestorPlace. More From InvestorPlace Why Ever...

Other stocks mentioned: CSCO, CVS, FDX, IGT, PPL, T
GlobeNewsWire - 1 month ago

TEMPLE CITY, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio...

GlobeNewsWire - 1 month ago

TEMPLE CITY, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio...

Zacks Investment Research - 2 months ago

Top Ranked Momentum Stocks to Buy for November 17th

Other stocks mentioned: CTHR, RM, SMLR
Zacks Investment Research - 2 months ago

Investment in momentum stocks with a favorable Zacks Rank may be fruitful in the near term. These include Fulgent Genetics (FLGT), II-VI (IIVI), General Motors (GM), Flagstar Bancorp (FBC) and...

Other stocks mentioned: FBC, GM, IIVI, LEA
Seeking Alpha - 2 months ago

Two new breakout stocks for Week 47 with better than 10% short-term upside potential. This past week one out of four stocks gained over 10%+ with YCBD +19.5% at the peak and the portfolio clos...

Other stocks mentioned: CSCO, CVX, GS, HON, IBM, INTC, JPM, PG, UNH, VERI, VZ
OTC PR Wire - 2 months ago

The Virus Testing Stocks Pullback Opportunity (NASDAQ: CODX) (NASDAQ: FLGT) (OTC: ALST) (NYSE: LH)

Other stocks mentioned: CODX, LH, ALST
GlobeNewsWire - 2 months ago

TEMPLE CITY, Calif., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solutio...

The Motley Fool - 2 months ago

Coronavirus testing demand caused revenue and profit to surge last quarter.

Seeking Alpha - 2 months ago

Fulgent Genetics, Inc.'s (FLGT) CEO Ming Hsieh on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha - 2 months ago

Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh on Q3 2020 Results - Quick Version Earnings Call Transcript

Seeking Alpha - 2 months ago

Fulgent has a successful genetic testing business growing at 50% that should benefit from the reduced cost of sequencing. However, more recently, Fulgent's COVID-19 business has seen greater s...

GlobeNewsWire - 2 months ago

TEMPLE CITY, Calif., Oct. 26, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced that it will release its third quarter 2020 f...

GuruFocus - 3 months ago

Growth-focused investors may want to consider investing in the following small-cap stocks, as they represent companies whose trailing 12-month pro forma earnings per share (EPS) improved drama...

Other stocks mentioned: EIGI, LLNW
GlobeNewsWire - 3 months ago

Fulgent Genetics will provide routine RT-PCR testing for the ODRC’s approximately 14,000 employees Fulgent Genetics will provide routine RT-PCR testing for the ODRC’s approximately 14,000 empl...

CNBC Television - 4 months ago

Fulgent Genetics partners with NYC public schools on Covid-19 testing

With students returning to school, the largest public school district in the U.S.

GlobeNewsWire - 4 months ago

Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform

Zacks Investment Research - 4 months ago

Fulgent Genetics (FLGT) saw a big move last session, as its shares jumped nearly 12% on the day, amid huge volumes.

GlobeNewsWire - 4 months ago

TEMPLE CITY, Calif., Sept. 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a technology company providing comprehensive testing solu...

The Motley Fool - 4 months ago

New York City will use the company's COVID-19 test in its public school system.

Zacks Investment Research - 4 months ago

Increased analyst coverage over the last few weeks might lead to solid price appreciation for these stocks.

Other stocks mentioned: ALDX, NIU, PRIM, SURF
GlobeNewsWire - 4 months ago

COVID-19 and Influenza A/B will be run on single nasal swab at no additional cost to patients COVID-19 and Influenza A/B will be run on single nasal swab at no additional cost to patients

GlobeNewsWire - 4 months ago

Test and Trace (T2) Program will use Picture by Fulgent at-home test for hundreds of thousands of students to help ensure a safe return to school Test and Trace (T2) Program will use Picture b...

CNBC Television - 4 months ago

Small caps lag the broader market, so is there opportunity?

Nancy Prial, Essex Investment Management portfolio manager, on whether there's opportunity among small cap stocks. With CNBC's Dominic Chu and the Fast Money traders, Guy Adami, Karen Finerman...

Other stocks mentioned: ELF, IWM, PS
The Motley Fool - 4 months ago

The Nasdaq Composite failed to hit a record for the first time in a week.

Other stocks mentioned: FLDM

About FLGT

Fulgent Genetics, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. The company primarily serves hospitals and medical institutions. It sells its tests through internal sales force, as well as through independent sales representatives in the United States and internationally. Fulgent Genetics h... [Read more...]

Industry
Diagnostics & Research
IPO Date
Sep 29, 2016
CEO
Ming Hsieh
Employees
473
Stock Exchange
NASDAQ
Ticker Symbol
FLGT
Full Company Profile

Financial Performance

In 2019, FLGT's revenue was $32.53 million, an increase of 52.35% compared to the previous year's $21.35 million. Losses were -$411,000, -92.67% less than in 2018.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for FLGT stock is "Buy." The 12-month stock price forecast is 62.50, which is a decrease of -9.73% from the latest price.

Price Target
$62.50
(-9.73% downside)
Analyst Consensus: Buy